Sarepta Therapeutics
SRPT
SRPT
409 hedge funds and large institutions have $10.2B invested in Sarepta Therapeutics in 2022 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 125 increasing their positions, 127 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 373 → 409 (+36)
2% less repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 127
6.84% less ownership
Funds ownership: 96.71% → 89.86% (-6.8%)
Holders
409
Holding in Top 10
13
Calls
$371M
Puts
$246M
Top Buyers
| 1 | +$68.4M | |
| 2 | +$67.7M | |
| 3 | +$51.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39.3M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$38.9M |
Top Sellers
| 1 | -$898M | |
| 2 | -$72.3M | |
| 3 | -$51.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$49.5M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$42.9M |